Rank 38 • AI & Clinical Intelligence
Paige
Designs AI-powered digital pathology solutions to aid pathologists in detecting and diagnosing complex cancers.
Visit website- Signal Score
- 88.3
- Total raised
- $220M
- Stage
- Series C
- Founded
- 2017
- Headquarters
- New York, USA
- Region
- North America
Their signal
Paige was the first to receive FDA de novo clearance for AI in digital pathology, establishing it as a foundational leader in oncology-focused clinical decision support.
Signal Score 88.3editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Did we miss something?
Change, add or remove details on this company. Our desk reviews every request.
Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.